Citation: Rj. Wyatt et Rj. Hogg, Evidence-based assessment of treatment options for children with IgA nephropathies, PED NEPHROL, 16(2), 2001, pp. 156-167
Authors:
Sorof, JM
Urbina, EM
Cunningham, RJ
Hogg, RJ
Moxey-Mims, M
Eissa, MA
Rolf, C
Citation: Jm. Sorof et al., Screening for eligibility in the study of antihypertensive medication in children: Experience from the Ziac Pediatric Hypertension Study, AM J HYPERT, 14(8), 2001, pp. 783-787
Authors:
Hogg, RJ
Portman, RJ
Milliner, D
Lemley, KV
Eddy, A
Ingelfinger, J
Citation: Rj. Hogg et al., Evaluation and management of proteinuria and nephrotic syndrome in children: Recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE), PEDIATRICS, 105(6), 2000, pp. 1242-1249
Authors:
Powell, DR
Durham, SK
Brewer, ED
Frane, JW
Watkins, SL
Hogg, RJ
Mohan, S
Citation: Dr. Powell et al., Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: A report of the southwest pediatric nephrology study group, J CLIN END, 84(2), 1999, pp. 596-601